12 November 2019, Sofia Hotel Balkan
This site uses cookies. For more information, please follow this link. OK

The event

About the Event:
For the sixth consecutive year, Capital Weekly will host a conference dedicated to the health sector in Bulgaria. 
The health economy continues to grow and is one of the most innovative sectors, but it also  faces huge challenges on its path to the future. Here are some of the highlight questions that will be covered in the 2019 event: 
How will the health care model change and what are the lessons learned in other countries? What policies will the EU implement to foster innovation? How will digitalization change the field? What technology will change the face of health care? Can Bulgaria rely on healthcare as a major economic growth factor, and how? What are the steps to attracting investment in the field, developing health and spa tourism, medicine manufacturing, clinical trials, education and development, and what is the return? Which are the technologies that change the sector? What is the future of medicine? 

The event will also host the Second Annual Awards for Innovations and Good Practices in the Health Sector, which distinguish the people and companies that drive the sector forward. 

Topic in the Agenda:
 - Innovation in the sector - Reforms in the health care model and lessons learned from abroad 
 - How does the EU promote innovation
Digital health
New trends in laboratory equipment and diagnostic technology
Hospital healthcare
Second annual awards for innovations and good practices in the health sector 

300+participants, health authorities - Ministry of Health, National Health Insurance Fund, Ministry of Finance, Bulgarian Medical Association, representatives of major political parties, managers and representatives of medical facilities, physicians, business representatives, pharmaceutical companies, professional organizations’ representatives

When and Where:
November 12th, 2019, Sofia Hotel Balkan

Early-bird registration fee (till October 21): 150 BGN excl. 20% VAT
Standard participation fee (after October 21): 200 BGN excl. 20% VAT

* This event is restricted for people under the age of 18


  • Prof. Assen Baltov, MD, DSc

    Prof. Assen Baltov, MD, DSc CEO, University General and Emergency Medicine Hospital "N.I. Pirogov"

    Prof. Baltov is the Executive Director of Emergency General Hospital "N.I. Pirogov" since February 2017. Previously, he has been the head of the First Emergency Clinic at the University Emergency Hospital. From April 1st, 2019 he is the coordinator of the Expert Council of Orthopedics and Rheumatology at the Ministry of Health. He was born on September 19th, 1966 in Sofia. In 1984 he graduated from the 22nd GSU Rakovski European School of Social Sciences - gr. Sofia. In 1994 he graduated from the Medical University - Sofia. Two years later, he began his specialization in orthopedics and traumatology at the Second Traumatology Clinic of Emergency General Hospital "N.I. Pirogov". He works in the hospital until December 2006. From the end of 2006 to February 2013 he was a resident at the Department of Orthopedic Traumatology and Reconstructive Surgery - Medical Military Academy. Specialist in the field of surgical treatment of fractures and joints of the limbs and pelvis; treatment of polytrauma and post-traumatic limb injuries; endoprosthesis of upper limb joints - shoulder and elbow. In June 2016 he received the scientific degree of "Professor". He is currently chairing the Bulgarian Orthopedic-Traumatology Association, being a member there since 1997. Member of EFORT since 2003 3.; AO Alumni Association Bulgaria - since 2005; International Kuncher Association - since 2009; AO Trauma Bulgaria - since 2010; AO Trauma Europe - since 2011. He has participated in more than 100 international congresses and summits with international participation.
    Speaks Russian, French and English.

  • Ivan Madzharov, MD

    Ivan Madzharov, MD Chairman, Bulgarian Medical Association

    Dr. Ivan Madzharov is elected Chairman of the Physicians' Professional Organization of the 68th Regular Election Summit of the Bulgarian Doctors' Union in June 2018. Prior to the presidency of the BDU, he was CEO of  "Pulmed" Hospita,  Plovdiv and Chairman of the Board of the Bulgarian Hospital Association. From 2013 to 2014 he has been the governor Regional Health Insurance Fund Plovdiv. From 2008 to 2013 he has been "Parvomay" hospital  CEO. From 1994 to 2008 he has been a resident at the ENT Department at "Plovdiv" Hospital. Dr. Ivan Madzharov graduated from the Medical University of Plovdiv. He has a specialty in Ear, Nose and Throat Diseases and a Master's Degree in Health Management.
  • Prof. Assena Stoimenova, MScPharm

    Prof. Assena Stoimenova, MScPharm Member of the Management Board of the European Medicines Agency, member of the CHMP (Committee for Medicinal Products for Human Use)

  • Lora Ivcheva

    Lora Ivcheva Sanofi Genzyme

  • Rouslana Toncheva

    Rouslana Toncheva CEO, Janssen Bulgaria

    Rouslana Toncheva is the CEO of Janssen for Bulgaria, the pharmaceutical division of the largest healthcare company in the world Johnson & Johnson. She is an expert with more than 15 years of experience in the pharmaceutical industry, she has held numerous local and international management positions at multinational innovative pharmaceutical companies before leading the Bulgarian Janssen team. Rouslana Toncheva has a Master's Degree in Economics from UNWE Sofia and MBA in "General Management" from Rotterdam School of Management, she is also a guest lecturer at Webster University Geneva and the American University in Bulgaria.
  • Slaveyko Djambazov, MD, PhD

    Slaveyko Djambazov, MD, PhD CEO, НТА

    Graduated English language boarding school (1995), medicine (2001), healthcare management (2007), MBA (2010). Dr Djambazov is a serial entrepreneur and was part of the team, which built the first GMP-certified pharmaceutical plant in Bulgaria (2004), a network of hospitals for the treatment of myocardial infarction, saving thousands of lives (2008), then a network of chemotherapy clinics, treating >30% of cancer patients in the country (2013), currently involved in the improvement of the outpatient care and mass introduction of telemedicine (2015 - now). Dr Djambazov is involved in more than 20 other companies as a co-founder, investor, advisor or friend. He teaches healthcare management and introduces health technology assessment (HTA) in Bulgaria, co-authors textbooks and scientific papers, frequent public speaker.
  • Prof. Petko Salchev, MD, DSC

    Prof. Petko Salchev, MD, DSC Classification Systems, Standards and Innovation Director, NCPHA

  • Deyan Denev

    Deyan Denev CEO ARPharM

    Deyan Denev is heading the Association of Research-based Pharmaceutical Manufacturers in Bulgaria since October 2003. He has a legal education from Sofia University and is an expert in pharmaceutical legislation and pharmaceutical policy. As Director of the association he is leading the advocacy activities of R&D pharmaceutical industry in Bulgaria on key issues regarding pharmaceutical policy, regulatory environment, intellectual property, pharmaceutical market development.
    He was a member of the Supervisory Board of the National Health Insurance Fund on behalf of the Confederation of Employers and Industrialists in Bulgaria from January 2014 to January 2015.
    Between 2008 and 2013 he was a representative of the pharmaceutical industry in the Transparency Commission, which is an appeal body for all piecing and reimbursement decisions in Bulgaria. He is a co-chair of the Central and Eastern European Task Force of EFPIA (European Federation of Pharmaceutical Industries and Associations).
    In 2019 Mr. Denev is chairing the Bulgarian Medicines Verification Organization.
  • Illiana Paunova,

    Illiana Paunova, CEO, BgMVO

    Iliana Paunova is Executive Director of the Bulgarian Organization for the Verification of Medicines (BOVL). The association was established in April 2016 by the five organizations representing stakeholders in the implementation of Directive 2011/62 / EU in Bulgaria.

    Prior to that, she was the Commercial Director for the Adriatic Region in GlaxoSmithKline (GSK) and the General Manager of GSK for Bulgaria. At that time she has been also the President and Vice-President of the Association of Research-Based Pharmaceutical Manufacturers (ARPharM). For more than 20 years Iliana Paunova has been working for the development of the pharmaceutical industry in our country and for the introduction of innovative business projects and programs for corporate social responsibility. She holds a degree in computer science from UNWE and specializations in finance, marketing and management at INSEAD, Henley Business School, MIT Sloan School of Management, etc.

  • Kountcho Trifonov MD

    Kountcho Trifonov MD Manager at Health PR

    Kountcho Trifonov, MD, MBA is healthcare and pharmaceutical sector professional with 6 years of experience as GM of biopharmaceutical company (NV Organon -1997-2003) and more than 14 years of experience as GM of healthcare and pharmaceutical sector servicing company (IMS Health – 2003-2017), along with 6 years of experience as academic teaching physician as Assistant Professor in Internal Medicine (1991-1997). The strong assets of Dr. K. Trifonov include but are not limited to complex consulting projects management, extensive data collecting and processing projects, client servicing outsourcing processes, call centers management, sales force effectiveness consulting and efficacy improvements. Recent involvement of Dr. K. Trifonov – numerous projects in Digital Healthcare and in detail in digital communication tools with HCP for pharmaceutical industry.
  • Prof. Asen Dudov

    Prof. Asen Dudov Head of Medical Oncology Clinic, Acibadem City Clinic Cancer Center

  • Dr. Med. Todor Finkov, MBA

    Dr. Med. Todor Finkov, MBA HighPoint Solutions and Independent consulting

    Business Development professional with strong medical and business background with country and international experience and cross sector exposure. Extensive experience in product launch and commercialization, opportunities identification, business expansion, project management and process governance. Extensive experience with institutional partnering and commercial market access. In depth experience with specialty care products, biosimilars and off patent products in Europe, Russia & CIS and Middle East markets.
    A proven ability to work in diverse environments and lead cross-functional teams to support execution of business objectives. Skillfully manages, collaborates and implements processes across large cross-functional and cross-regional teams. Excellent at forging effective peer-to-peer relationships with internal and external stakeholders. Highly focused professional with strong business acumen, interpersonal skills and impeccable integrity.  
  • Marc Schreiner

    Marc Schreiner CEO of the Hospital Federation of Berlin, Member of the Board of the German Hospital Federation, Chair of the "Committee on EU and international affairs" of the German Hospital Federation

  • Gizelle Baker

    Gizelle Baker Director Global Scientific Engagement, Philip Morris International

  • Prof. Zdravko Kamenov, MD, PhD, DMSc, FACE, FECSM

    Prof. Zdravko Kamenov, MD, PhD, DMSc, FACE, FECSM Head of the Clinic of Endocrinology, Alexandrovska University hospital, Sofia, Bulgaria and Chair of the Department of Internal diseases, Medical University of Sofia

    Graduated at Medical University of Sofia. Specialties in Internal medicine, Endocrinology and metabolic disorders, Sexual medicine, Public health and health management. Specializations in Japan, Austria, Italy, USA. Founder of the specialized centre for prevention of diabetes and its complications in Alexandrovska University hospital in Sofia. Fellow of the American College of Endocrinology and the AACE. Fellow of the European Committee for Sexual Medicine


Draft Agenda

8.30 – 9.00 Registration and coffee

9.00 Official Opening

Dr. Daniela Daritkova, Chair of the Parliamentary Healthcare Committee
Zheny Nacheva - Deputy Minister of Health (c)
Ivan Madzharov, MD, Chairman, Bulgarian Medical Association
Prof. Ilko Getov, President of the Bulgarian Pharmaceutical Union
Announcement of the Second Annual Awards for Innovations and Good Practices in the Healthcare Sector
9.30 - 10.30  First Panel "Innovations in the Healthcare Sector
- Changes in the Healthcaree Model and Foreign Countries Models "
Moderator: Kountcho Trifonov, MD, Manager of Health PR

Budget 2020 - expectations, hopes and realities - Prof. Grigor Dimitrov, NHIF Advisory Board Member and Chief Director of the Bulgarian Industrial Association Social Security Directorate
Innovations in oncology -  Prof. Asen Dudov, DSc, Head of Medical Oncology Clinic, Acibadem City Clinic Cancer Center
Future of medicines or medicines of the future -  Dr. Svetoslav Tsenov, Director of Astellas for Bulgaria, Vice-chairman, Association of Research-based Pharmaceutical Manufacturers Bulgaria (ARPharM Bulgaria) 

How EU encorages innovation - Deyan Denev, CEO, ARPharM 

Speech by the competition winner
Innovations in the general health prophylaxis and provision of satisfactory healthcare status of German population -  Marc Schreiner, CEO of the Berlin Hospital Federation, Member of the Board of the German Hospital Federation and Chairman of the  EU Affairs Committee related to the German Hospital Federation
Financing of healthcare promotion services – Prof. Petko Salchev, MD, DSC, Classification Systems, Standards and Innovation Director, NCPHA
Population Health Impact Model - Gizelle Baker, MD, PhD, Director Global Scientific Engagement, Philip Morris International

Innovations in Diabetes - Prof. Zdravko Kamenov, MD, DSc, Head of Endoclinology, University General Hospital "Alexandrovska"

10.30 – 11.45 Second Panel - "Innovations in common diseases therapy"

Moderator: Prof. Assena StoimenovaMScPharm

Innovation - the role of the regulator -Bogdan Kirilov, Bulgarian Drug Agency Executive Director

Innovative Therapies - Cost or Value? - Dr. Krasimira Cemishanska, CEO of Amgen Bulgaria and Chairman of the Association of Research-Based Pharmaceutical Manufacturers in Bulgaria (ARPharM)

How health innovations meet the high patients’ demand for new therapies? - Lora Ivcheva, CEO of Sanofi Bulgaria, General Manager Sanofi Genzyme South-East & Central Europe

Pharmaceutical Innovation role in healthcare change - Konstantinos Papagianis, CEO of MSD for Bulgaria

Improving adherence to patient therapy based on actual clinical practice and patient programs - Alexander Alexiev, CEO, SAT Health

11.45 - 12.00  Coffee break

12.00 - 13.30 Тhird Panel  "Digital Healthcare"

Moderator: Dr. Branimir Raduilov, Consultant in eHealth and Medical Technology
The patient of the future: why knowledge matters – Rouslana Toncheva, CEO, Janssen Bulgaria

Benefits of Foundation Medicine Services - comprehensive genomic profiling in clinical practice, Dr. Radoslav Mangaldzhiev

Real World Data: principles and implementation - Slaveyko Djambazov, MD, PhD, CEO, НТА

New technologies and patients’ safety  – Mariya Sharkova, Healthcare Attorney 

Bulgarian Medicines Verification System after 9/02/2019 – Illiana Paunova, CEO, BgMVO

13.30 - 14.30 Lunch

14.30 - 16.00 Forth Panel "Hospital Healthcare"

Moderator:  Ivan Madzharov, MD, Chairman, Bulgarian Medical Association

The succesful hospitals:

University General and Emergency Medicine Hospital "N.I. Pirogov" resstructuring  – 
Prof. Assen Baltov, MD, DSc, CEO, University General and Emergency Medicine Hospital "N.I. Pirogov"
Successful model for private hospitals development - Dr. Ivan Kolchakov, member of "Sofiamed" Hospital management

Specialized Physiatric Hospital "Dimitar Gramatikov, MD" - Rousse – Svetoslav Datchev, MD, CEO
Hospitals of the Future - Dr. Todor Finkov, consultant


Abbvie nagradi Astellas Amgen Sanofi Novo Nordisk Pfizer Takeda Janssen MSD Roche Bulfarma bgmvo PMI SAT Health ArPharm


Contact us for any questions about Economedia's events